News Center

The PLGA Fund at PBTF Sponsors PLGG/PLGA Coalition Meeting in Germany

January 17th, 2020|

On Monday, January 13, 2020, the PLGG/PLGA Coalition kicked off their 4th meeting in 6 years to discuss the most current scientific studies and best practices in clinical trials […]

The Power of Human Cancer Genetics as Revealed by Pediatric Low-Grade Glioma

December 15th, 2019|

Through a unique international partnership between the PLGA Research Program at DFCI, the Everest Center PLGA Research Program at the German Cancer Research Center and Research Institute of the […]

The 8th Annual Camp Sunshine Pediatric Low-grade Astrocytoma Brain Tumor Week 2019

November 26th, 2019|

The 8th Annual Camp Sunshine Pediatric Low-grade Astrocytoma Brain Tumor Week 2019 was a “SOLD OUT” family experience with PLGA families from 17 different states and 1 European country […]

Caught in the Act

October 30th, 2019|

First snapshots of cancer protein B-Raf illuminate basic biology, and can impact drug design for pediatric low grade glioma brain tumor patients.
Researchers at the Blavatnik Institute at Harvard Medical […]

Pediatric Brain Tumor Foundation and American Association for Cancer Research Announce RFP for Research Grant to Optimize Drug Dosing Strategies for PLGA Patients

September 24th, 2019|

The Pediatric Brain Tumor Foundation’s PLGA Fund and the American Association for Cancer Research (AARC) are excited to announce a request for proposals for the inaugural Research Grant to […]

Study Results: New PLGA Research Demonstrates the Power of Teamwork in Improving Outcomes for Kids with Brain Tumors

August 28th, 2019|

Children diagnosed with low-grade astrocytomas, the most common type of pediatric brain tumor, have close to 90 percent overall survival rates. However, the growth of the tumors and the […]

Pediatric Brain Tumor Foundation and A Kids’ Brain Tumor Cure Join Forces to Change the Outcome for All Children with Brain Cancer

November 13th, 2018|

ASHEVILLE, N.C. and BOSTON — The Pediatric Brain Tumor Foundation (PBTF) and A Kids’ Brain Tumor Cure (AKBTC, a/k/a PLGA Foundation) are merging to take a massive leap forward […]

Attainment of Functional and Social Independence in Adult Survivors of Pediatric CNS Tumors: A Report from the St Jude Lifetime Cohort Study

September 17th, 2018|

Beyond survival, achieving independence is a primary goal for adult survivors of pediatric CNS tumors. Researchers at St. Jude recently concluded a comprehensive assessment of independence in survivors of […]

Clinical Trials and Expanded Access to Experimental Drugs/Devices Get a Boost from Recent Legislation

September 4th, 2018|

When you or a family member is diagnosed with a serious or life-threatening disease, you have choices to make about your treatment once standard treatment options are exhausted. Two […]

A Phase I Study of PLX8394 Plus Ritonavir in Children with Recurrent or Progressive BRAF Activated Gliomas

June 13th, 2018|

A Phase I Study of PLX8394 Plus Ritonavir in Children with Recurrent or Progressive BRAF Activated Gliomas

Principal Institutions: Children’s Hospital of Los Angeles in partnership with the Pediatric Brain […]